163 related articles for article (PubMed ID: 33517175)
1. ELTD1 as a biomarker for multiple sclerosis: Pre-clinical molecular-targeted studies in a mouse experimental autoimmune encephalomyelitis model.
Towner RA; Smith N; Zalles M; Morris S; Toliver M; Saunders D; Lerner M; Kumar G; Axtell RC
Mult Scler Relat Disord; 2021 Apr; 49():102786. PubMed ID: 33517175
[TBL] [Abstract][Full Text] [Related]
2. Targeting ELTD1, an angiogenesis marker for glioblastoma (GBM), also affects VEGFR2: molecular-targeted MRI assessment.
Ziegler J; Zalles M; Smith N; Saunders D; Lerner M; Fung KM; Patel M; Wren JD; Lupu F; Battiste J; Towner RA
Am J Nucl Med Mol Imaging; 2019; 9(1):93-109. PubMed ID: 30911439
[TBL] [Abstract][Full Text] [Related]
3. ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models.
Ziegler J; Pody R; Coutinho de Souza P; Evans B; Saunders D; Smith N; Mallory S; Njoku C; Dong Y; Chen H; Dong J; Lerner M; Mian O; Tummala S; Battiste J; Fung KM; Wren JD; Towner RA
Neuro Oncol; 2017 Feb; 19(2):175-185. PubMed ID: 27416955
[TBL] [Abstract][Full Text] [Related]
4. Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model.
Zalles M; Smith N; Ziegler J; Saunders D; Remerowski S; Thomas L; Gulej R; Mamedova N; Lerner M; Fung KM; Chung J; Hwang K; Jin J; Wiley G; Brown C; Battiste J; Wren JD; Towner RA
J Cell Mol Med; 2020 Jan; 24(2):1738-1749. PubMed ID: 31863639
[TBL] [Abstract][Full Text] [Related]
5. Assessment of an scFv Antibody Fragment Against ELTD1 in a G55 Glioblastoma Xenograft Model.
Zalles M; Smith N; Saunders D; Saran T; Thomas L; Gulej R; Lerner M; Fung KM; Chung J; Hwang K; Jin J; Battiste J; Towner RA
Transl Oncol; 2020 Mar; 13(3):100737. PubMed ID: 32208341
[TBL] [Abstract][Full Text] [Related]
6. In vivo MR imaging of intercellular adhesion molecule-1 expression in an animal model of multiple sclerosis.
Blezer EL; Deddens LH; Kooij G; Drexhage J; van der Pol SM; Reijerkerk A; Dijkhuizen RM; de Vries HE
Contrast Media Mol Imaging; 2015; 10(2):111-21. PubMed ID: 24753465
[TBL] [Abstract][Full Text] [Related]
7. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric magnetic resonance imaging for detection of pathological changes in the central nervous system of a mouse model of multiple sclerosis in vivo.
Althobity AA; Khan N; Sandrock CJ; Woodruff TM; Cowin GJ; Brereton IM; Kurniawan ND
NMR Biomed; 2023 Oct; 36(10):e4964. PubMed ID: 37122101
[TBL] [Abstract][Full Text] [Related]
9. Imaging B Cells in a Mouse Model of Multiple Sclerosis Using
James ML; Hoehne A; Mayer AT; Lechtenberg K; Moreno M; Gowrishankar G; Ilovich O; Natarajan A; Johnson EM; Nguyen J; Quach L; Han M; Buckwalter M; Chandra S; Gambhir SS
J Nucl Med; 2017 Nov; 58(11):1845-1851. PubMed ID: 28687602
[TBL] [Abstract][Full Text] [Related]
10. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
11. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
[TBL] [Abstract][Full Text] [Related]
12. Intestinal MAdCAM-1 imaging as biomarker for prognostic in murine models of multiple sclerosis.
Baudron E; Martinez de Lizarrondo S; Gauberti M; Delaunay-Piednoir B; Fournier AP; Vivien D; Docagne F; Bardou I
Brain Behav Immun; 2024 Jul; 119():381-393. PubMed ID: 38604270
[TBL] [Abstract][Full Text] [Related]
13. A tale of two multi-focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone-based OKN-007.
Zalles M; Smith N; Saunders D; Lerner M; Fung KM; Battiste J; Towner RA
J Cell Mol Med; 2022 Jan; 26(2):570-582. PubMed ID: 34910361
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system targeted autoimmunity causes regional atrophy: a 9.4T MRI study of the EAE mouse model of Multiple Sclerosis.
Hamilton AM; Forkert ND; Yang R; Wu Y; Rogers JA; Yong VW; Dunn JF
Sci Rep; 2019 Jun; 9(1):8488. PubMed ID: 31186441
[TBL] [Abstract][Full Text] [Related]
15. Efficient Distribution of a Novel Zirconium-89 Labeled Anti-cd20 Antibody Following Subcutaneous and Intravenous Administration in Control and Experimental Autoimmune Encephalomyelitis-Variant Mice.
Migotto MA; Mardon K; Orian J; Weckbecker G; Kneuer R; Bhalla R; Reutens DC
Front Immunol; 2019; 10():2437. PubMed ID: 31681317
[No Abstract] [Full Text] [Related]
16. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of Experimental Autoimmune Encephalomyelitis in Mice by Interferon-Beta Gene Therapy, Using a Long-Term Expression Plasmid Vector.
Hamana A; Takahashi Y; Tanioka A; Nishikawa M; Takakura Y
Mol Pharm; 2017 Apr; 14(4):1212-1217. PubMed ID: 28257578
[TBL] [Abstract][Full Text] [Related]
18. Development of a CD19 PET tracer for detecting B cells in a mouse model of multiple sclerosis.
Stevens MY; Cropper HC; Lucot KL; Chaney AM; Lechtenberg KJ; Jackson IM; Buckwalter MS; James ML
J Neuroinflammation; 2020 Sep; 17(1):275. PubMed ID: 32948198
[TBL] [Abstract][Full Text] [Related]
19. ELTD1 as a multi-focal target for malignant gliomas: preclinical studies.
Zalles M; Smith N; Saunders D; Guzman M; Lerner M; Fung KM; Babu A; Battiste J; Chung J; Hwang K; Jin J; Towner RA
Neurooncol Adv; 2021; 3(1):vdab132. PubMed ID: 34704036
[TBL] [Abstract][Full Text] [Related]
20. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
Hu X; Qin X
Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
